UBS Group
NEOG icon

UBS Group’s Neogen NEOG Stock Holding History

UBS Group’s Portfolio NEOG Stock Details NEOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,333
Closed -$23K – 8721
2015
Q1 		$23K Sell
1,333
-1,334
-50% -$24.4K ﹤0.01% 6852
2014
Q4 		$50K Buy
+2,667
New +$43.9K ﹤0.01% 6483

Other funds holding NEOG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

UBS Group's NEOG Position: Q2 2026 in Review

UBS Group increased its Neogen (NEOG) stake by 11% in Q2 2026, buying an estimated $1.51M and bringing the position to 1,677,343 shares worth $15.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2986.

UBS Group first reported a position in NEOG in Q4 2014 and has held it in 47 quarters since. The position peaked at $42.9M in Q4 2024. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • UBS Group held 1,677,343 shares of Neogen worth $15.1M as of Q2 2026.
  • UBS Group bought 164,879 Neogen shares in Q2 2026, an estimated $1.51M.
  • Neogen made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2986 holding.
  • UBS Group first reported a position in Neogen in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Neogen position peaked at $42.9M in Q4 2024.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.